REBACIN® can remove high-risk Human Papillomavirus (HPV) persistent infection efficiently as an effective non-invasive treatment: a multicenter prospective study

Abstract Objective To evaluate the efficacy of REBACIN® as a non-invasive treatment for persistent high-risk HPV (HR-HPV) clearance compared with interferon and no treatment, identify optimal cutoff values for HPV E6/E7 mRNA/DNA assays, analyze clinical predictors, and validate REBACIN® as a safe al...

Cijeli opis

Bibliografski detalji

Glavni autori:	Jie-Jie Li, Su-Su Yang, Kang-Jia Chen, Li-Shuai Jiang, Ya-Xing Fang, Chun-Li Liu, Sheng Wang, Chun Ye, Liang-Feng Yao, Yu-Qi Chen, Xiao Li, Jing Jiang, Feng-Ming He, Yu-Li Ling, Shu-Guang Zhou
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2026-04-01
Serija:	World Journal of Surgical Oncology
Teme:	High-risk HPV Clearance rate Efficacy Rate Recombinant human interferon α-2b REBACIN®
Online pristup:	https://doi.org/10.1186/s12957-026-04378-4
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!